The Role of the Pharmacist in Managing Sexual Dysfunction is organized by College of Psychiatric and Neurologic Pharmacists (CPNP) and will be held from May 16, 2019 - Apr 08, 2022. This Course has been approved for a maximum of 1.0 Contact Hours.
This course is designed for pharmacists, nurse practitioners or other health care professionals involved in the comprehensive medication management of psychiatric and/or neurological patients.
The discussion of sexual dysfunction can be a difficult topic for patients to discuss with their providers, and the diagnoses of sexual disorders and treatment options continue to evolve. After attending this presentation, participants will have a greater understanding of the spectrum of sexual dysfunction among men and women, feel comfortable initiating routine discussion of sexual function/dysfunction with patients, and gain confidence in making recommendations for changes in pharmacotherapy options tailored to the individual/sexual problem and supporting patient initiation of conversations with their prescriber.
You will proceed through the following steps to satisfactorily complete this course:
• Review the full content of the activity and reflect upon its teachings.
• Complete the post-test at the end of the activity no later than the closing activity date. (login first)
• Complete the evaluation at the end of the activity. (login first)
• If necessary, complete the post-test retest no later than the closing activity date. (login first)
• Receive a passing grade (70%).
• Provide the necessary details in your profile to ensure correct reporting by CPNP to CPE Monitor. (login first)
• Identify the spectrum of sexual dysfunction described in various nomenclatures: ICD-10, DSM-IV and -5, and other nomenclatures.
• Describe the prevalence and causes of sexual dysfunction and its impact on the mental health patient population.
• Explain how to screen for sexual dysfunction and how to obtain a thorough sexual history.
• Outline new developments, current treatment options, and adverse effects of the pharmacotherapy options in the treatment of sexual dysfunction.
Additional details will be posted as soon as they are available.
Pharmacy and Medicine, Obstetrics and Gynecology, Andrology, Psychiatry